madman
Super Moderator
This video webinar discusses the prognosis and survival rates of prostate cancer. The speaker explains that prostate cancer is the most common cancer in men and that survival rates depend on the stage and type of cancer. For localized prostate cancer, the survival rate after five years is almost 100%. Even for metastatic cancers, the five-year survival rate is 50%. The speaker also discusses the factors that influence prognosis, such as age, stage, and PSA levels. It is important for patients to stay informed about the disease, maintain good physical health, and seek support from experts and support networks.
Key Takeaways:
*Prostate cancer is the most common cancer in men.
*Survival rates depend on the stage and type of cancer.
*For localized prostate cancer, the 5-year survival rate is almost 100%.
*Metastatic prostate cancer has a 5-year survival rate of 50%.
*Age, stage, and PSA levels influence prognosis.
*Patients with prostate cancer can live 20-30 years with or without treatment.
*Maintaining good physical health is important for improving prognosis.
*It is important to understand the disease and seek support from experts.
*The Prostate Cancer Support Line is available for patients.
*Proactive Foundation offers tools, resources, and support for prostate cancer.
